Drug
Meropenem Plus Vaborbactam
Meropenem Plus Vaborbactam: highest development phase Phase 2, developed by Menarini. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Menarini
Trials
| Drug | Phase | Indication |
|---|---|---|
| Meropenem plus vaborbactam NCT06828848 | Phase 2 | Gram Negative Infections |
Latest
No recent events.
Follow Meropenem Plus Vaborbactam on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.